Recent research suggests that vitamin D could play a significant role in pain management, particularly after surgery. A study published in the journal Regional Anesthesia & Pain Medicine by researchers from Fayoum University in Egypt found that women with low vitamin D levels reported higher pain levels and required significantly more opioid medication following breast cancer surgery.
Read More
The study involved 184 female patients scheduled for elective one-sided modified radical mastectomy. Participants were tested for vitamin D levels and divided into two groups: those with sufficient levels of vitamin D and those who were deficient. The medical staff treating the patients were unaware of the patients’ vitamin D status. All patients received similar pain management, including fentanyl during surgery and intravenous acetaminophen afterward, along with the option to self-administer tramadol.
Findings indicated that patients deficient in vitamin D were three times more likely to experience moderate to severe pain in the first 24 hours post-surgery compared to those with adequate levels. While no severe pain was reported in either group, the vitamin D-deficient patients utilized more opioid medication to manage their discomfort. Additionally, these patients experienced more side effects, such as nausea, while none of the adequate vitamin D group vomited after surgery.
Although the study indicates a correlation between vitamin D deficiency and increased postoperative pain, researchers noted limitations. The observational nature of the study, confined to a single treatment center, prevents definitive conclusions about causation. Other factors like inflammation, depression, or sleep issues, which could influence pain levels, were not assessed.
Researcher findings align with broader evidence suggesting vitamin D's importance in pain regulation, potentially due to its anti-inflammatory properties. Previous studies have linked low vitamin D levels to increased pain and higher requirements for opioid medication, suggesting that vitamin D supplements may alleviate pain particularly in patients who start treatment with insufficient levels.
Further studies are necessary to verify these findings, as current evidence indicates vitamin D supplementation has not led to adverse effects and is straightforward to administer. A UK study published in Therapeutic Advances in Musculoskeletal Disease also highlighted vitamin D's potential connection to chronic pain and called for more research to clarify its role and therapeutic effectiveness.